
Neuronetics STIM
$ 1.3
1.97%
Quarterly report 2025-Q3
added 11-04-2025
Neuronetics Long Term Debt Current 2011-2026 | STIM
Annual Long Term Debt Current Neuronetics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 824 K | 670 K | 594 K | 559 K | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 824 K | 559 K | 662 K |
Long Term Debt Current of other stocks in the Diagnostics research industry
| Issuer | Long Term Debt Current | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
2.18 M | - | -6.23 % | $ 30.6 M | ||
|
ICON Public Limited Company
ICLR
|
24.3 M | $ 98.33 | 0.9 % | $ 8.11 B | ||
|
Akumin
AKU
|
17.2 M | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
77 K | - | -6.19 % | $ 10.5 M | ||
|
Brainsway Ltd.
BWAY
|
824 K | $ 13.71 | -0.22 % | $ 99.4 M | ||
|
Charles River Laboratories International
CRL
|
57.7 M | $ 155.46 | 1.83 % | $ 7.71 B | ||
|
Bioventus
BVS
|
3.3 M | $ 8.62 | 0.23 % | $ 574 M | ||
|
DexCom
DXCM
|
21.6 M | $ 64.24 | -1.56 % | $ 25.1 B | ||
|
Castle Biosciences
CSTL
|
1.66 M | $ 25.56 | 0.95 % | $ 710 M | ||
|
CareDx, Inc
CDNA
|
6.52 M | $ 17.01 | 3.4 % | $ 906 M | ||
|
Accelerate Diagnostics
AXDX
|
829 K | - | -61.36 % | $ 2.46 M | ||
|
Exact Sciences Corporation
EXAS
|
33.6 M | $ 103.57 | 0.29 % | $ 19.5 B | ||
|
Guardant Health
GH
|
27.7 M | $ 85.49 | 1.75 % | $ 10.7 B | ||
|
Global Cord Blood Corporation
CO
|
147 K | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
264 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
21.5 M | - | 0.12 % | $ 80.1 M | ||
|
Fulgent Genetics
FLGT
|
1.44 M | $ 14.77 | 0.61 % | $ 447 M | ||
|
Biodesix
BDSX
|
719 K | $ 17.88 | -6.63 % | $ 2.32 B | ||
|
Anixa Biosciences
ANIX
|
41 K | $ 2.83 | -1.05 % | $ 91.8 K | ||
|
Danaher Corporation
DHR
|
199 M | $ 187.32 | 0.57 % | $ 134 B | ||
|
IQVIA Holdings
IQV
|
93 M | $ 164.72 | 1.1 % | $ 28.3 B | ||
|
Biocept
BIOC
|
518 K | - | -13.05 % | $ 7.29 M | ||
|
Heska Corporation
HSKA
|
2.94 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
475 K | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
79 M | $ 118.94 | 2.92 % | $ 18.9 B | ||
|
Quest Diagnostics Incorporated
DGX
|
174 M | $ 199.7 | -0.46 % | $ 22.2 B | ||
|
QIAGEN N.V.
QGEN
|
23.4 M | - | - | $ 10.6 B | ||
|
BioNano Genomics
BNGO
|
2.99 M | $ 1.11 | -0.89 % | $ 1.41 M | ||
|
DarioHealth Corp.
DRIO
|
111 K | $ 9.0 | -0.99 % | $ 255 M | ||
|
Neogen Corporation
NEOG
|
5.64 M | $ 9.09 | -2.78 % | $ 1.97 B | ||
|
National Research Corporation
NRC
|
451 K | $ 16.52 | 0.12 % | $ 370 M | ||
|
Chembio Diagnostics
CEMI
|
915 K | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
264 K | - | - | $ 9.42 M | ||
|
Pacific Biosciences of California
PACB
|
448 K | $ 1.33 | 4.72 % | $ 399 M | ||
|
Co-Diagnostics
CODX
|
838 K | - | - | $ 79.8 M | ||
|
Medpace Holdings
MEDP
|
23.2 M | $ 450.41 | 1.48 % | $ 13 B | ||
|
Celcuity
CELC
|
172 K | $ 114.22 | 3.11 % | $ 4.51 B | ||
|
DermTech
DMTK
|
3.07 M | - | -11.32 % | $ 2.94 M | ||
|
Mettler-Toledo International
MTD
|
35.1 M | $ 1 173.74 | 0.49 % | $ 24.2 B | ||
|
Personalis
PSNL
|
7.7 M | $ 6.72 | 1.97 % | $ 398 M | ||
|
NeoGenomics
NEO
|
4.78 M | $ 7.88 | -1.25 % | $ 1.01 B | ||
|
Enzo Biochem
ENZ
|
841 K | - | -8.98 % | $ 14.8 K | ||
|
Natera
NTRA
|
7.64 M | $ 187.85 | -1.29 % | $ 18.5 B | ||
|
Sotera Health Company
SHC
|
5.76 M | $ 13.42 | 0.71 % | $ 3.81 B | ||
|
Invitae Corporation
NVTA
|
14.6 M | - | - | $ 21.2 M | ||
|
OPKO Health
OPK
|
12.6 M | $ 1.19 | 2.59 % | $ 826 M |